Meeting Program

To view program in "24 hour" time (international) click here.

Friday, April 1
3:00 - 7:30 PM	Registration	Foyer
6:30 - 7:30 PM	Refreshments	Foyer
7:30 - 8:30 PM	Keynote Address Registered attendees for this meeting can view Abstracts for this session starting on 03/01/2011	Colorado Ballroom
	Diane J. Mathis, Harvard Medical School, USA Control of Autoimmunity and Immune Homeostasis
Saturday, April 2
7:00 - 8:00 AM	Breakfast	Summit Gallery
8:00 - 11:30 AM	Transcriptional Control of Immune Regulation Registered attendees for this meeting can view Abstracts for this session starting on 03/01/2011	Colorado Ballroom
	* Hilde Cheroutre, La Jolla Institute for Allergy and Immunology, USA
	Steven F. Ziegler, Benaroya Research Institute, USA Regulation and Role of Foxp3 in Regulatory T Cells
	Jonathan S. Bromberg, University of Maryland School of Medicine, USA Induction, Migration, and Function of Treg
	Drew M. Pardoll, Johns Hopkins University School of Medicine, USA Novel Transcription Factors that Control Treg Development and Function
	Short Talk to be Chosen from Abstracts,
	Daniel Campbell, Benaroya Research Institute, USA Functional Specialization of Foxp3+ Regulatory T Cells
	Mark S. Anderson, University of California, San Francisco, USA Modulation of Peripheral Tolerance by AIRE
9:20 - 9:40 AM	Coffee Break	Foyer
11:30 AM- 1:00 PM	Poster Setup	Breckenridge Ballroom
1:00 - 10:00 PM	Poster Viewing	Breckenridge Ballroom
5:00 - 5:45 PM	Coffee Available	Foyer
5:00 - 7:00 PM	Molecular Mechanics of Regulation Registered attendees for this meeting can view Abstracts for this session starting on 03/01/2011	Colorado Ballroom
	* Steven F. Ziegler, Benaroya Research Institute, USA
	Alexander Y. Rudensky, Memorial Sloan-Kettering Cancer Center, USA Transcriptional Modulation of Treg Development and Function
	Jonathan D. Powell, Johns Hopkins School of Medicine, USA Modulation of Regulatory Pathways by TOR
	Short Talk to be Chosen from Abstracts,
	Douglas R. Green, St. Jude Children's Research Hospital, USA Metabolic Perturbation, Apoptotic Drive and Regulatory Lineage Commitment
7:00 - 8:00 PM	Social Hour w/ Lite Bites	Breckenridge Ballroom
7:30 - 10:00 PM	Poster Session 1 Registered attendees for this meeting can view Abstracts for this session starting on 03/01/2011	Breckenridge Ballroom
Sunday, April 3
7:00 - 8:00 AM	Breakfast	Summit Gallery
8:00 - 11:00 AM	Treg Development and Immunomodulation Registered attendees for this meeting can view Abstracts for this session starting on 03/01/2011	Colorado Ballroom
	* Douglas R. Green, St. Jude Children's Research Hospital, USA
	Chyi-Song Hsieh, Washington University, USA Factors that Modulate Thymic Treg Development
	David Artis, University of Pennsylvania, School of Veterinary Medicine, USA Immunoregulation at Mucosal Surfaces
	Peter B. Ernst, University of Virginia, USA Immunomodulation by Adenosine
	Greg E. Lemke, The Salk Institute for Biological Studies, USA Immunomodulation by TAM Receptors
	Short Talk(s) to be Chosen from Abstracts,
9:20 - 9:40 AM	Coffee Break	Foyer
11:30 AM- 1:00 PM	Poster Setup	Breckenridge Ballroom
1:00 - 10:00 PM	Poster Viewing	Breckenridge Ballroom
5:00 - 5:45 PM	Coffee Available	Foyer
5:00 - 7:00 PM	Workshop 1: Molecular Immunoregulatory Networks Registered attendees for this meeting can view Abstracts for this session starting on 03/01/2011	Peak 5
	* Diane J. Mathis, Harvard Medical School, USA
	Short Talks to be Chosen from Abstracts, ,
5:00 - 7:00 PM	Workshop 2: Cellular Immunoregulatory Networks Registered attendees for this meeting can view Abstracts for this session starting on 03/01/2011	Peaks 1-4
	* Jeffrey A. Bluestone, University of California, San Francisco, USA
	Short Talks to be Chosen from Abstracts, ,
7:00 - 8:00 PM	Social Hour w/ Lite Bites	Breckenridge Ballroom
7:30 - 10:00 PM	Poster Session 2 Registered attendees for this meeting can view Abstracts for this session starting on 03/01/2011	Breckenridge Ballroom
Monday, April 4
7:00 - 8:00 AM	Breakfast	Summit Gallery
8:00 - 11:30 AM	Cytokine Modulation of Regulatory Networks Registered attendees for this meeting can view Abstracts for this session starting on 03/01/2011	Colorado Ballroom
	* Alexander Y. Rudensky, Memorial Sloan-Kettering Cancer Center, USA
	Dario A.A. Vignali, St. Jude Children's Research Hospital, USA Interleukin-35 and Treg Function
	Christopher A. Hunter, University of Pennsylvania, USA IL-10, IL-27 and Treg Function
	Casey T. Weaver, University of Alabama at Birmingham, USA Modulation of Regulatory Networks by Cytokines
	Short Talk to be Chosen from Abstracts,
	Anne O'Garra, National Institute for Medical Research, UK IL-10 and Immunoregulation
	Randolph J. Noelle, King's College London, UK Tregs Mast Cells and Retinoic Acid
9:20 - 9:40 AM	Coffee Break	Foyer
11:30 AM- 1:00 PM	Poster Setup	Breckenridge Ballroom
1:00 - 10:00 PM	Poster Viewing	Breckenridge Ballroom
5:00 - 5:45 PM	Coffee Available	Foyer
5:00 - 7:00 PM	Novel Regulators and Other Interesting Regulatory Mechanisms Registered attendees for this meeting can view Abstracts for this session starting on 03/01/2011	Colorado Ballroom
	* Christopher A. Hunter, University of Pennsylvania, USA
	Shimon Sakaguchi, Institute for Frontier Medical Sciences, Kyoto University, Japan Manipulation of Tregs and their Mode of Action
	Short Talk to be Chosen from Abstracts,
	Thomas F. Tedder, Duke University Medical Center, USA Regulatory B10 B Cells during Health and Disease
	Dmitry I. Gabrilovich, University of South Florida, USA Myeloid Suppressor Cells and Tumors
7:00 - 8:00 PM	Social Hour w/ Lite Bites	Breckenridge Ballroom
7:30 - 10:00 PM	Poster Session 3 Registered attendees for this meeting can view Abstracts for this session starting on 03/01/2011	Breckenridge Ballroom
Tuesday, April 5
7:00 - 8:00 AM	Breakfast	Summit Gallery
8:00 - 11:30 AM	Cell Surface Modulators of Regulatory Networks and Immunotherapy Registered attendees for this meeting can view Abstracts for this session starting on 03/01/2011	Colorado Ballroom
	* Drew M. Pardoll, Johns Hopkins University School of Medicine, USA
	Michael Croft, La Jolla Institute for Allergy and Immunology, USA TNFR Family Members and the Induction of Tregs
	Bruce R. Blazar, University of Minnesota, USA Treg-Based Immunotherapy in Hematopoietic Stem Cell Transplantation
	Richard M. Maizels, University of Edinburgh, UK Tregs Induced by Helminths
	Short Talk to be Chosen from Abstracts,
	Arlene H. Sharpe, Harvard Medical School, USA Immunomodulation by PD1
	Suzanne L. Topalian, Johns Hopkins University School of Medicine, USA Antibody-Based Immunotherapy
9:20 - 9:40 AM	Coffee Break	Foyer
5:00 - 5:45 PM	Coffee Available	Foyer
5:00 - 7:00 PM	Plasticity of Regulatory Populations Registered attendees for this meeting can view Abstracts for this session starting on 03/01/2011	Colorado Ballroom
	* Dario A.A. Vignali, St. Jude Children's Research Hospital, USA
	Hilde Cheroutre, La Jolla Institute for Allergy and Immunology, USA Cellular Plasticity and Treg Function
	Sidonia Fagarasan, RIKEN Research Center for Allergy and Immunology, Japan Plasticity of Tregs in Germinal Centers
	Short Talk to be Chosen from Abstracts,
	Jeffrey A. Bluestone, University of California, San Francisco, USA Modulation of the Treg Phenotype in Autoimmunity
7:00 - 8:00 PM	Social Hour w/ Lite Bites	Breckenridge Ballroom
8:00 - 11:00 PM	Entertainment	Breckenridge Ballroom
Wednesday, April 6
	Departure
*=Session Chair     †=Speaker invited, not yet responded.

Immunoregulatory networks play a pivotal role in preventing autoimmunity, but also restrict anti-tumor immunity and modulate immune responses to pathogens. While regulatory T cells (Tregs) are a central component of this network, there is now the growing realization that there are many other cellular and molecular components that contribute to this network. While this will be is a Treg-centric meeting, it will also focus on how Tregs integrate with other cellular and molecular components to prevent autoimmunity and control immune responses. This meeting will dissect our current understanding of four key areas: development and homeostasis of regulatory populations, molecular control of immunoregulatory networks, mechanisms of regulatory function and regulatory T cell plasticity. A second goal will be to discuss how Tregs interact with different cells types or utilize different cytokines that modulate or indirectly mediate their activity. A third goal will be to assess how the advances presented can be utilized to develop novel therapies for autoimmune disease and cancer.